| Hang Seng Index | 25.600 HKD | +0.140 | +0.550% | 367.82M | 9.39B | 25.489 (+0.434%) HKD as at 2025/07/21 | | |
| Hang Seng China Enterprises | 92.820 HKD | +0.220 | +0.238% | 87.76M | 8.11B | 91.997 (+0.895%) HKD as at 2025/07/18 | | |
| Hang Seng TECH Index | 5.495 HKD | +0.015 | +0.274% | 922.98M | 5.06B | 5.487 (+0.142%) HKD as at 2025/07/21 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng TECH Index | 5.665 HKD | +0.030 | +0.532% | 135.89M | 766.32M | 5.654 (+0.191%) HKD as at 2025/07/21 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng TECH Index | 1.536 HKD | -0.012 | -0.775% | 265.09M | 409.45M | 1.542 (-0.376%) HKD as at 2025/07/21 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng Index | 2.018 HKD | -0.022 | -1.078% | 145.36M | 294.66M | 2.038 (-0.972%) HKD as at 2025/07/21 | | |
| Hang Seng TECH Index | 11.770 HKD | +0.020 | +0.170% | 23.65M | 278.11M | 11.666 (+0.892%) HKD as at 2025/07/18 | | |
| FTSE China A50 | 14.930 HKD | +0.170 | +1.152% | 12.01M | 178.93M | 14.773 (+1.062%) HKD as at 2025/07/18 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng Index | 5.760 HKD | +0.065 | +1.141% | 29.36M | 168.41M | 5.707 (+0.922%) HKD as at 2025/07/21 | | |
| Mirae Asset US Treasury 3-5 Year Index | 55.880 HKD | +0.040 | +0.072% | 2.83M | 157.75M | 55.822 (+0.105%) HKD as at 2025/07/18 | | |
| Hang Seng TECH Index | 5.580 HKD | +0.015 | +0.270% | 20.85M | 116.10M | 5.524 (+1.019%) HKD as at 2025/07/18 | | |
| HSI ESG Enhanced Index (net total return index) | 52.720 HKD | +0.300 | +0.572% | 2.11M | 111.01M | 52.587 (+0.253%) HKD as at 2025/07/21 | | |
| Hang Seng China Enterprises | 10.790 HKD | +0.010 | +0.093% | 10.01M | 107.97M | 10.714 (+0.707%) HKD as at 2025/07/18 | | |
| CSI 300 | 47.080 HKD | +0.440 | +0.943% | 1.81M | 85.00M | 46.728 (+0.753%) HKD as at 2025/07/21 | | |
| FTSE China A50 | 13.910 HKD | +0.120 | +0.870% | 5.99M | 82.82M | 13.812 (+0.710%) HKD as at 2025/07/21 | | |
| MSCI Asia APEX 50 | 64.600 HKD | -0.180 | -0.278% | 1.19M | 76.85M | 64.609 (-0.013%) HKD as at 2025/07/18 | | |
| London Gold Fixing Price | 2,450.000 HKD | +17.000 | +0.699% | 21.17K | 51.86M | N/A | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Solactive Gold 1-Day Rolling Futures Index | 17.510 HKD | +0.240 | +1.390% | 2.86M | 50.15M | 17.117 (+2.295%) HKD as at 2025/07/18 | | |
| Hang Seng Hong Kong-Listed Biotech Index | 15.780 HKD | +0.150 | +0.960% | 2.87M | 45.41M | 15.666 (+0.729%) HKD as at 2025/07/21 | | |
| Hang Seng Index | 23.380 CNY | +0.100 | +0.430% | 1.04M | 24.32M | 23.305 (+0.320%) CNY as at 2025/07/21 | | |
| CME CF Ether-Dollar Reference Rate - Asia Pacific Variant | 8.820 HKD | -0.310 | -3.395% | 2.53M | 22.63M | 9.107 (-3.147%) HKD as at 2025/07/21 | | |
| FTSE US Treasury 20+ Years Index | 67.260 HKD | +0.040 | +0.060% | 266.96K | 17.98M | 66.599 (+0.992%) HKD as at 2025/07/18 | | |
| Hang Seng High Dividend Yield | 29.940 HKD | +0.440 | +1.492% | 519.87K | 15.49M | 29.056 (+3.044%) HKD as at 2025/07/18 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | CSI 300 | 4.008 HKD | +0.090 | +2.297% | 3.77M | 14.95M | 3.899 (+2.806%) HKD as at 2025/07/18 | | |
| CME Ether Futures | 17.530 HKD | -0.600 | -3.309% | 802.91K | 14.27M | 16.941 (+3.479%) HKD as at 2025/07/18 | | |
| CME CF Bitcoin Reference Rate- Asia Pacific Variant | 14.620 HKD | -0.160 | -1.083% | 802.18K | 11.68M | 14.773 (-1.032%) HKD as at 2025/07/21 | | |
| CSI China Reform Hong Kong Connect Central-SOEs High Dividend Yield Index | 10.070 HKD | +0.180 | +1.820% | 1.07M | 10.64M | 9.840 (+2.337%) HKD as at 2025/07/21 | | |
| CME Bitcoin Futures | 40.140 HKD | -0.500 | -1.230% | 253.14K | 10.12M | 39.948 (+0.481%) HKD as at 2025/07/18 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | NASDAQ-100 Index | 3.882 HKD | -0.002 | -0.051% | 2.49M | 9.62M | 3.907 (-0.627%) HKD as at 2025/07/18 | | |
| CSI Hong Kong Dividend | 37.500 HKD | +0.020 | +0.053% | 187.53K | 7.04M | 37.542 (-0.112%) HKD as at 2025/07/21 | | |